HSP70 inhibitors upregulate prostaglandin E1-induced synthesis of interleukin-6 in osteoblasts

Interleukin-6 (IL-6) is a pro-inflammatory and bone-resorptive cytokine that also regulates bone formation. We previously showed that prostaglandin E1 (PGE1) induces the synthesis of IL-6 by activating p44/p42 mitogen-activated protein kinase (MAPK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 MAPK in osteoblast-like MC3T3-E1 cells. In the present study, we investigated whether heat shock protein 70 (HSP70), a molecular chaperone that coordinates protein folding and homeostasis, affects PGE1-stimulated IL-6 synthesis in MC3T3-E1 cells through the MAPK activation. The osteoblast-like MC3T3-E1 cells were treated with HSP70 inhibitors—VER-155008 and YM-08—, PD98059, SB203580 or SP600125 and then stimulated with PGE1. IL-6 synthesis was evaluated using an IL-6 enzyme-linked immunosorbent assay kit. IL-6 mRNA expression was measured by real-time RT-PCR. The phosphorylation of p38 MAPK was evaluated by Western blotting. We found that VER-155008, an HSP70 inhibitor, enhanced the PGE1-stimulated IL-6 release and IL-6 mRNA expression. YM-08, another HSP70 inhibitor, also enhanced PGE1-stimulated IL-6 release. PD98059, a p44/p42 MAPK inhibitor, and SP600125, a SAPK/JNK inhibitor, upregulated PGE1-stimulated IL-6 release. On the other hand, SB203580, a p38 MAPK inhibitor, suppressed PGE1-stimulated IL-6 release. YM-08 stimulated the PGE1-induced phosphorylation of p38 MAPK. SB203580 suppressed the amplification by YM-08 of the PGE1-stimulated IL-6 release. Our results suggest that HSP70 inhibitors upregulate the PGE1-stimulated IL-6 synthesis through p38 MAPK in osteoblasts and therefore affect bone remodeling.

[1]  O. Kozawa,et al.  HSP70 Inhibitors Reduce The Osteoblast Migration By Epidermal Growth Factor. , 2019, Current molecular medicine.

[2]  O. Kozawa,et al.  HSP70 Inhibitor Suppresses IGF-I-Stimulated Migration of Osteoblasts through p44/p42 MAP Kinase , 2018, Biomedicines.

[3]  Jae Young Kim,et al.  Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-κB Activation in Human Myeloid Leukemia THP-1 Cells , 2018, BioMed research international.

[4]  Huiyong Shen,et al.  Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells , 2018, Stem Cell Research & Therapy.

[5]  E. Craig.  Hsp70 at the membrane: driving protein translocation , 2018, BMC Biology.

[6]  O. Kozawa,et al.  Heat Shock Protein 70 Negatively Regulates TGF-β-Stimulated VEGF Synthesis via p38 MAP Kinase in Osteoblasts , 2017, Cellular Physiology and Biochemistry.

[7]  Hong Wang,et al.  The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review , 2015, Cell Stress and Chaperones.

[8]  O. Kozawa,et al.  Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. , 2014, Archives of biochemistry and biophysics.

[9]  M. Mayer,et al.  Functional Analysis of Hsp70 Inhibitors , 2013, PloS one.

[10]  Toshiharu Suzuki,et al.  Suppression of Alzheimer’s Disease-Related Phenotypes by Geranylgeranylacetone in Mice , 2013, PloS one.

[11]  J. Brodsky,et al.  Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels. , 2013, ACS chemical neuroscience.

[12]  M. Sabbieti,et al.  Prostaglandin F2α: A bone remodeling mediator , 2013, Journal of cellular physiology.

[13]  Jiake Xu,et al.  An overview of the regulation of bone remodelling at the cellular level. , 2012, Clinical biochemistry.

[14]  N. Gusev,et al.  Large potentials of small heat shock proteins. , 2011, Physiological reviews.

[15]  Andreas Bracher,et al.  Molecular chaperones in protein folding and proteostasis , 2011, Nature.

[16]  N. Fazzalari,et al.  Bone fracture and bone fracture repair , 2011, Osteoporosis International.

[17]  L. Raisz,et al.  Prostaglandins in bone: bad cop, good cop? , 2010, Trends in Endocrinology & Metabolism.

[18]  Takao Shimizu,et al.  The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. , 2008, Progress in lipid research.

[19]  J. Luk,et al.  Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat‐shock proteins (Hsp27, Hsp70, GRP78) up‐regulation and their associated prognostic values , 2006, Proteomics.

[20]  A. Ishisaki,et al.  Involvement of SAPK/JNK in prostaglandin E1-induced VEGF synthesis in osteoblast-like cells , 2004, Molecular and Cellular Endocrinology.

[21]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[22]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[23]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  O. Kozawa,et al.  p38 mitogen-activated protein (MAP) kinase but not p44/p42 MAP kinase is involved in prostaglandin E1-induced vascular endothelial growth factor synthesis in osteoblasts. , 2001, The Journal of endocrinology.

[25]  M. Bostrom,et al.  Bone growth factors. , 2000, The Orthopedic clinics of North America.

[26]  O. Kozawa,et al.  Modulation of the Stress‐Induced Synthesis of hsp27 and αB‐Crystallin by Cyclic AMP in C6 Rat Glioma Cells , 1996, Journal of neurochemistry.

[27]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[28]  T. Martin,et al.  Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.

[29]  S. Akira,et al.  Interleukin-6 family of cytokines and gp130. , 1995, Blood.

[30]  Philip R. Cohen,et al.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.

[31]  D R Ciocca,et al.  Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. , 1993, Journal of the National Cancer Institute.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[33]  Bin Chen,et al.  Guidelines for the nomenclature of the human heat shock proteins , 2008, Cell Stress and Chaperones.

[34]  O. Kozawa,et al.  Specific induction of heat shock protein 27 by glucocorticoid in osteoblasts , 2002, Journal of cellular biochemistry.

[35]  O. Kozawa,et al.  Prostaglandin E1 stimulates interleukin-6 secretion via protein kinase A in osteoblast-like cells. , 1997, Cellular signalling.

[36]  O. Kozawa,et al.  Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. , 1992, Experimental cell research.